UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000012604
Receipt No. R000014738
Scientific Title Effect of the REduced form of COenzyme Q10 Supplementation on endothelial function in chronic heart failure
Date of disclosure of the study information 2013/12/17
Last modified on 2019/07/02 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of the REduced form of COenzyme Q10 Supplementation on endothelial function in chronic heart failure
Acronym RECOQS
Scientific Title Effect of the REduced form of COenzyme Q10 Supplementation on endothelial function in chronic heart failure
Scientific Title:Acronym RECOQS
Region
Japan

Condition
Condition chronic heart failure
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify whether ubiquinol improves endothelial function in chronic heart failure patients or not.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Changes in endothelial function assessed by EndoPAT 2000 between before and after intervention.
Key secondary outcomes Changes in functional capacity, left ventricular function, oxydative stress marker, inflammation marker, and COQ10 concentration in peripheral blood.

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 Ubiquinol 200mg twice daily, 12 weeks, followed by placebo 12 weeks
Interventions/Control_2 Placebo 12 weeks, followed by Ubiquinol 200mg twice daily, 12 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
90 years-old >
Gender Male and Female
Key inclusion criteria Chronic heart failure patients whose left ventricular ejection fraction are less than 40 %.
Key exclusion criteria Malignancy, severe infection, severe trauma, hemodialysis.
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Kazuo
Middle name
Last name Kimura
Organization Yokohama City University Medical Center
Division name Division of Cardiology
Zip code 2320024
Address 4-57 Urafune-cho, Minami-ku, Yokohama
TEL 045-261-5656
Email c-kimura@urahp.yokohama-cu.ac.jp

Public contact
Name of contact person
1st name Masaaki
Middle name
Last name Konishi
Organization Yokohama City University Medical Center
Division name Division of Cardiology
Zip code 2320024
Address 4-57 Urafune-cho, Minami-ku, Yokohama
TEL 045-261-5656
Homepage URL
Email m_koni@yokohama-cu.ac.jp

Sponsor
Institute Yokohama City University Medical Center
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Yokohama City University Medical Center
Address 4-57 Urafune-cho, Minami-ku, Yokohama
Tel 045-261-5656
Email chihirou@yokohama-cu.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 12 Month 17 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 06 Month 01 Day
Date of IRB
2012 Year 11 Month 21 Day
Anticipated trial start date
2013 Year 06 Month 02 Day
Last follow-up date
2014 Year 10 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2013 Year 12 Month 17 Day
Last modified on
2019 Year 07 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000014738